3rd Party Biotechnology Industry News

Renowned biotech veteran Robert Langer is the executive chair of [...]

After Carisma Therapeutics laid off 95% of its team earlier [...]

Biogen has given Alcyone Therapeutics a starring role in its [...]

VectorY Therapeutics has seen the shape of things to come—and [...]

Having already stripped back their development plans for the estrogen [...]

Roche dived into the metabolic dysfunction-associated steatohepatitis space by agreeing [...]

Beijing QL Biopharmaceutical has shared phase 2 data on its [...]

One of the top fundraisers of 2024 is halving its [...]

California VC firm Aditum Bio is at it again, this [...]

After being touted as a potential rival to Bristol Myers [...]